Abstract: A system and method may retrieve transaction data for a plurality of electronic payment system transactions. The transaction data may describe a plurality of electronic payment transactions between a payment network system and a plurality of merchants. The transaction data may include a transaction location and a merchant store number. The system and method may parse the transaction data to identify the transaction location and the merchant store number and analyze the retrieved and parsed transaction data to identify one or more centroids for at least a portion of the retrieved and parsed transaction data. The one or more centroids may correspond to a merchant location for each transaction of the retrieved and parsed transaction data. The system and method may then clean the retrieved and parsed transaction data having a transaction location outside a threshold distance from the one or more centroids to include accurate merchant store number data.

Abstract: A converged enclosure is provided. The converged enclosure comprises a base panel, a housing coupled with the base panel and a plurality of ports housed on a front surface of the housing. The plurality of ports is arranged in a plurality of rows such that each row has one or more ports. The one or more ports in each of the plurality of rows is inclined at a predefined row angle (R1, R2, R3, R4) from a vertical base axis such that the predefined row angle of each of the plurality of rows is different. The plurality of ports is arranged in a plurality of columns such that each column has one or more ports. The one or more ports in each of the plurality of columns is inclined at a predefined column angle (C1, C2, C3) from a horizontal base axis such that the predefined column angle of each of the plurality of columns is different.

Abstract: This disclosure describes systems, devices, apparatus, and methods, including computer programs encoded on storage media, for controlling a network with one or more access points (APs). A controller may be configured to schedule at least some resources of the one or more APs to improve network efficiency. The APs may measure and report a variety of information and statistics to the controller. The controller may determine one or more transmission parameters and one or more operations a given AP is permitted to perform during a respective time interval. The controller may communicate the one or more transmission parameters using an indication, such as a message. At least one AP associated with the controller may communicate with stations (STAs) using the one or more transmission parameters.

Abstract: Disclosed herein are sanitizing/disinfecting compositions comprising an ionic liquid comprising a choline cation and fatty acid anion for use in sanitizing or disinfecting surfaces. In some embodiments, the ionic liquid is further formulated as a surface disinfectant for inanimate surfaces.

Abstract: Disclosed herein, in certain embodiments, are gel formulations and compositions comprising anionic liquid comprising a choline cation and fatty acid anion. In some embodiments, the ionic liquid is further formulated for topical administration. In some embodiments, the gel formulations and compositions provided herein are useful for treating skin conditions and disorders such as rosacea.

Abstract: Disclosed herein are sanitizing compositions comprising an alcohol and non-volatile component. In certain embodiments, sanitizing compositions comprise an ionic liquid comprising a choline cation and fatty acid anion for use in sanitizing surfaces. In some embodiments, the ionic liquid is further formulated for topical administration.

Abstract: A converged enclosure is provided. The converged enclosure comprises a base panel, a housing coupled with the base panel and a plurality of ports housed on a front surface of the housing. The plurality of ports is arranged in a plurality of rows such that each row has one or more ports. The one or more ports in each of the plurality of rows is inclined at a predefined row angle (R1, R2, R3, R4) from a vertical base axis such that the predefined row angle of each of the plurality of rows is different. The plurality of ports is arranged in a plurality of columns such that each column has one or more ports. The one or more ports in each of the plurality of columns is inclined at a predefined column angle (C1, C2, C3) from a horizontal base axis such that the predefined column angle of each of the plurality of columns is different.

Abstract: One aspect of the present disclosure is directed to a method of delivering the RNAi agents to or through a skin. Another aspect of the present disclosure is directed to a method of reducing expression or translation of a target gene within a stratum corneum layer, an epidermis layer, a dermis layer, a subcutaneous tissue layer, or a muscle tissue. Another aspect of the present disclosure is directed to a topical composition, comprising the RNAi agents or a pharmaceutically acceptable salt thereof, and an ionic liquid in an amount sufficient to allow a therapeutically effective amount of the RNAi agents to reach a target depth within or beyond the skin.

Abstract: One aspect of the present disclosure is directed to a method of delivering tofacitinib to or through a skin. Another aspect of the present disclosure is directed to a method of locally inhibiting activity of at least one of JAK-1, JAK-2, TYK-2, and JAK-3 within an epidermis layer, a dermis layer, a subcutaneous tissue layer, or a muscle tissue. Another aspect of the present disclosure is directed to a topical composition, comprising tofacitinib or a pharmaceutically acceptable salt thereof, and an ionic liquid in an amount sufficient to allow a therapeutically effective amount of tofacitinib to reach a target depth within or beyond the skin.

Abstract: Method and compositions for inducing the self-renewal of stem/progenitor supporting cells comprised by a cochlear cell population, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair cells.

Abstract: Method and compositions for inducing the self-renewal of stem/progenitor supporting cells comprised by a cochlear cell population, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair cells.

Abstract: Disclosed are pharmaceutical compositions formulated for delivery to the brain of a subject. The compositions include a plurality of nanoparticles (NPs) containing a brain therapeutic agent, poly(lactic-co-glycolic acid) (PLGA), and a pharmaceutically acceptable excipient selected from the group consisting of a surfactant, peptide, and combinations thereof. Also disclosed are methods of their use.

Abstract: Self-assembled gels and methods of making thereof are described. A selective range of ratios between an organic solvent and optionally water, or an aqueous solution, allows for combinations of gelators (such as GRAS amphiphiles or prodrug-based gelators), co-gelators (such as anti-retrovirals), and solvents to form self-supporting hydrogels or organogels. The resulting gels may be used in methods of treating HIV and/or hepatitis.

Abstract: Self-assembled gels and methods of making thereof are described. A selective range of ratios between an organic solvent and optionally water, or an aqueous solution, allows for combinations of gelators (such as GRAS amphiphiles or prodrug-based gelators), co-gelators (such as anti-retrovirals), and solvents to form self-supporting hydrogels or organogels. The resulting gels may be used in methods of treating HIV and/or hepatitis.

Abstract: Disclosed herein, in certain embodiments, are anti-microbial and anti-inflammatory pharmaceutical compositions comprising an ionic liquid comprising a choline cation and fatty acid anion for use in the treatment of rosacea. In some embodiments, the ionic liquid is further formulated in a solvent or a gel base for topical administration.

Abstract: Method and compositions for inducing the self-renewal of stem/progenitor supporting cells comprised by a cochlear cell population, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair cells.

Abstract: Method and compositions for inducing the self-renewal of stem/progenitor supporting cells comprised by a cochlear cell population, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair cells.

Abstract: A self-assembled gel composition with enhanced adhesion to cartilage tissue is provided. A cationic agent co-self assembles with a generally regarded as safe (GRAS), low molecular weight (<2,500 Da) gelator, forming homogeneous self-supporting gel that can encapsulate one or more therapeutic agents for controlled release. The composition adheres to connective tissue, e.g., cartilage, to a greater extent and a greater length of time than a self-assembled gel from gelators alone. The composition is used to specifically target connective tissue and deliver one or more therapeutic, prophylactic, or diagnostic agents for controlled release to improve dosing efficacy.

Abstract: Self-assembled gels and methods of making thereof are described. A selective range of ratios between an organic solvent and optionally water, or an aqueous solution, allows for combinations of gelators (such as GRAS amphiphiles or prodrug-based gelators), co-gelators (such as anti-retrovirals), and solvents to form self-supporting hydrogels or organogels. The resulting gels may be used in methods of treating HIV and/or hepatitis.

Abstract: Method and compositions for inducing the self-renewal of stem/progenitor supporting cells comprised by a cochlear cell population, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair cells.